FIELD: medicine.
SUBSTANCE: composition containing an isolated native biologically active Sendai virus strain deposited in the American Type Culture Collection (ATCC) No. PTA-13024, and a pharmaceutically acceptable carrier, is administered into a patient. A group of inventions also refers to a pharmaceutical composition containing the isolated, genetically engineered, biologically active Sendai virus strain prepared on the basis of a viral material deposited in the American Type Culture Collection (ATCC) No. PTA-13024.
EFFECT: higher clinical effectiveness in treating oncological diseases ensured by the oncolytic action of Sendai virus and the viral stimulation of the antitumour immunity.
21 cl, 1 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING METASTATIC CANCER USING SENDAI VIRUS | 2017 |
|
RU2662916C1 |
| NEWCASTLE DISEASE VIRUS STRAIN FOR STUDYING ONCOLYTIC PROPERTIES AND MECHANISMS OF ONCOLYSIS TO CREATE PROTOTYPE ANTICANCER PREPARATION | 2014 |
|
RU2562115C1 |
| SET OF RECOMBINANT PLASMID DNA FOR OBTAINING RECOMBINANT VIRUSES SENDAI STRAIN MOSCOW (OPTIONS) | 2021 |
|
RU2787724C1 |
| NEWCASTLE DISEASE NDVH-2 VIRUS STRAIN FOR STUDY OF POSSIBILITY OF VIRAL ONCOLYTIC PREPARATION DEVELOPMENT ON ITS BASIS | 2016 |
|
RU2644676C1 |
| METHOD OF TREATING ONCOLOGICAL DISEASES | 2008 |
|
RU2379055C1 |
| PSCA-CAR-YT CELL LINE HAVING SURFACE EXPRESSION OF CHIMERIC ANTIGEN RECEPTORS AND EXHIBITING CYTOTOXIC ACTIVITY ON PSCA-POSITIVE HUMAN CANCER CELLS | 2018 |
|
RU2712901C1 |
| COMPOSITION CONTAINING PIC FOR CANCER TREATMENT | 2017 |
|
RU2728175C2 |
| METHOD FOR STIMULATING PRESENTING ACTIVITY OF DENDRITIC CELLS | 2019 |
|
RU2728592C1 |
| ATTENUATED STRAIN OF SENDAI VIRUS | 2013 |
|
RU2552487C2 |
| CONSTRUCTION OF OBLIGATE VECTOR BASED ON ONCOLYTIC HERPES SIMPLEX VIRUSES (oHSV) AND CONSTRUCTS FOR CANCER THERAPY | 2016 |
|
RU2751236C2 |
